Q-Line Biotech Financials

NSE: QLINE

₹628.85

₹30.55 (5.11%)

As on 16-Oct-2026IST

Market cap

₹1,467 Cr

Revenue (TTM)

₹342 Cr

P/E Ratio

26.3

P/B Ratio

5.8

Div. Yield

0 %

Income Statement (₹ Cr)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Operating Revenue	341.74	313.14	203.65	182.74	--	--
Total Income	347.44	325.22	206.45	184.81	--	--
Total Expenditure	243.64	251.50	165.58	148.99	--	--
EBITDA	98.10	61.64	38.06	33.75	--	--
Depreciation	10.79	7.03	3.93	2.14	--	--
EBIT	87.31	54.61	34.13	31.61	--	--
Interest	19.47	14.97	6.34	3.85	--	--
Other Income	5.70	12.08	2.80	2.08	--	--
Exceptional Items	-0.99	-16.97	--	--	--	--
Profit before Tax	72.55	34.74	30.60	29.84	--	--
Provision for Tax	16.83	19.06	8.96	8.46	--	--
Profit after Tax	55.72	15.68	21.64	21.38	--	--
Minority Interest	--	--	0.00	--	--	--
Share of Associate	--	3.53	12.80	10.71	--	--
Consolidated Profit	55.72	19.21	34.45	32.10	--	--

Liabilities (₹ Cr)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Shareholder's Funds	246.19	189.95	161.81	127.37	--	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	101.51	85.42	36.58	15.36	--	--
Current Liabilities	209.92	179.14	140.28	108.15	--	--
Total Liabilities	558.69	455.50	339.25	251.58	--	--

Assets (₹ Cr)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Non-Current Assets	213.57	189.88	140.14	74.76	--	--
Current Assets	344.06	264.64	198.53	176.11	--	--
Total Assets	558.69	455.50	339.25	251.58	--	--
Total Debt*	225.48	166.29	96.91	73.65	--	--
Net Current Assets	134.14	85.50	58.25	67.96	--	--
Contingent Liabilities	52.55	19.30	--	--	--	--

Cashflow (₹ Cr)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Cash From Operating Activities	16.38	17.21	-24.18	24.97	--	--
Cash Flow from Investing Activities	-29.42	-77.47	-44.69	-26.31	--	--
Cash from Financing Activities	41.64	53.18	16.99	26.40	--	--
Net Cash Inflow / Outflow	28.60	-7.08	-51.88	25.06	--	--

Financials Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Adjusted EPS (₹)	34.24	12.20	21.87	20.38	--	--
Cash EPS (₹)	40.87	14.42	16.23	14.93	--	--
Adjusted Book Value (₹)	151.27	120.61	102.74	80.87	--	--
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	10.06	109.27	-153.52	158.53	--	--
Free Cash Flow per Share (₹)	-18.50	-768.22	-493.38	-0.43	--	--

Profitability Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
ROCE (%)	22.23	16.17	16.07	16.76	--	--
ROE (%)	25.55	8.92	14.97	16.79	--	--
ROA (%)	11.01	3.95	7.34	8.52	--	--
EBIT Margin (%)	25.55	17.44	16.76	17.30	--	--
Net Margin (%)	16.04	4.82	10.48	11.57	--	--
Cash Profit Margin (%)	18.40	7.25	12.56	12.87	--	--

Growth Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Revenue Growth (%)	9.13	53.77	11.44	--	--	--
EBIT Growth (%)	59.88	59.97	7.97	--	--	--
Net Profit Growth (%)	255.32	-27.54	1.21	--	--	--
EPS Growth (%)	180.69	-44.23	7.33	--	--	--
Book Value Growth (%)	29.61	17.39	27.05	--	--	--

Valuation Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Price / Earnings	--	--	--	--	--	--
Price / Book Value	--	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	1.59	1.64	1.68	-0.41	--	--
Close Price (₹)	--	--	--	--	--	--
High Price (₹)	--	--	--	--	--	--
Low Price (₹)	--	--	--	--	--	--
Market Cap (₹ Cr)	--	--	--	--	--	--

Solvency Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debt to Equity	0.92	0.88	0.60	0.58	--	--
Short term debt to equity ratio	0.36	0.29	0.31	0.43	--	--
Current Ratio	1.64	1.48	1.42	1.63	--	--
Quick Ratio	1.19	0.97	0.67	1.23	--	--
Interest Coverage	4.73	3.32	5.83	8.75	--	--

Operating Efficiency Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debtors to sales (%)	36.82	26.38	12.99	18.09	--	--
Asset Turnover	0.71	0.79	0.69	0.73	--	--
Receivable days	105.22	63.55	53.32	66.03	--	--
Inventory Days	93.48	113.91	133.38	87.08	--	--
Payable days	146.52	143.30	194.12	163.82	--	--
Cash Conversion Cycle	52.17	34.16	-7.42	-10.72	--	--